Human Regenerative Technologies - About the company
Human Regenerative Technologies is an unfunded company based in El Segundo (United States), founded in 2016. It operates as an Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair. Human Regenerative Technologies has not raised any funding yet. The company has 165 active competitors, including 24 funded and 31 that have exited. Its top competitors include companies like BioLife Solutions, Integrated DNA Technologies and RoosterBio.
Company Details
Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair. Focused on developing human amniotic and placental properties through scientific understanding and advanced tissue allograft preservation. The company specializes in natural human tissue allografts derived from amniotic membranes and placental connective tissues. They advance tissue preservation technologies derived from the dynamic placental system, which provides the foundation of the body’s various tissues and organs. Their process utilizes sophisticated processing methods to capitalize on the full natural potential of the placenta, preserving function and integrity in their natural hydrated state while allowing for improved handling and delivery methods. They adhere to stringent donor screening, tissue testing, and safety standards. They are accredited by the American Association of Tissue Banks.
- Website
- humantissue.com
- Email ID
- *****@humantissue.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2016
Location
El Segundo, United States
Stage
Unfunded
Ranked
146th among 165 active competitors
Employee Count
1 as on Jul 31, 2026
Similar Companies
Sign up to download Human Regenerative Technologies' company profile
Human Regenerative Technologies's funding and investors
Human Regenerative Technologies has not raised any funding rounds yet.
Human Regenerative Technologies' founders and board of directors
Founder? Claim ProfileHuman Regenerative Technologies' employee count trend
Human Regenerative Technologies has 1 employees as of Jul 26. Here is Human Regenerative Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Human Regenerative Technologies's Competitors and alternates
Top competitors of Human Regenerative Technologies include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Human Regenerative Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
2nd | Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 63/100 | |
3rd | RoosterBio 2012, Frederick (United States), Series B | Developer of human mesenchymal stem cells and extracellular vesicles | $38.4M | 57/100 | |
4th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
5th | Shanghai Doning Biotechnology 2005, Shanghai (China), Series C | Provider of cell culture media | $14.9M | 53/100 | |
6th | ArcticZymes 2009, Tromso (Norway), Public | Developer of recombinant enzymes from various arctic species | - | 49/100 | |
7th | Toyobo 1882, New York City (United States), Public | Manufacturer of high performance materials including films and functional textiles | - | - | 49/100 |
8th | Multus 2019, London (United Kingdom), Series A | Provider of lab-grown meat alternatives | $9.3M | 45/100 | |
9th | Xcell Therapeutics 2015, Seoul (South Korea), Public | Provider of serum-free media for cell culture | - | 45/100 | |
10th | Biotangents 2015, Edinburgh (United Kingdom), Series A | Developer of diagnostic assays for infectious diseases in veterinary medicine | $5.62M | 45/100 | |
146th | Human Regenerative Technologies 2016, El Segundo (United States), Unfunded | Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair | - | - | 22/100 |
Looking for more details on Human Regenerative Technologies's competitors? Click here to see the top ones
Human Regenerative Technologies's Investments and acquisitions
Human Regenerative Technologies has made no investments or acquisitions yet.
Reports related to Human Regenerative Technologies
Here is the latest report on Human Regenerative Technologies's sector:
Are you a Founder ?
FAQs about Human Regenerative Technologies
Explore our recently published companies
- Moov - Unfunded company
- Repairtech - India based, Unfunded company
- UP! - Leiden based, 2007 founded, Unfunded company
- Rasta - India based, 2012 founded, Unfunded company
- Jara Pro Diseno grafico/Imprenta/websites/Grabacion y edicion de videos - Houston based, 2017 founded, Unfunded company
- Stewartperformancehorses - Unfunded company